1-1 of 1
Jennifer Pulini
Close
Sort by
Journal Articles

Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma

Clinical Trials & Observations
Tycel J. Phillips, Andres Forero-Torres, Taimur Sher, Catherine S. Diefenbach, Patrick Johnston, Moshe Talpaz, Jennifer Pulini, Li Zhou, Peggy Scherle, Xuejun Chen, Paul M. Barr
Journal: Blood
Blood (2018) 132 (3): 293–306.
https://doi.org/10.1182/blood-2017-10-812701
Published: 2018
Includes: Supplemental data